+4,437.1%
SNDK vs THC
+106.0%
+4,331.1%
-56.5%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 10y.
| Period | Portfolio | THC | Excess | Alpha |
|---|---|---|---|---|
| 1D | -3.5% | +0.1% | -3.6% | -3.5% |
| 7D | -6.1% | -0.5% | -5.6% | -6.0% |
| 30D | +21.5% | -1.2% | +22.7% | +21.8% |
| 3M | -13.2% | +52.3% | -65.5% | -28.0% |
| 6M | +149.2% | +12.4% | +136.8% | +142.4% |
| YTD | +588.1% | +32.7% | +555.4% | +504.9% |
| 1Y | +1,837.5% | +36.4% | +1,801.2% | +1,566.6% |
| All | +4,437.1% | +106.0% | +4,331.1% | +3,046.2% |
Cumulative growth
Daily Returns
Daily percentage return beside THC.
Daily Out/Under-Performance
Portfolio return minus THC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × THC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 10y: compounded portfolio wealth divided by compounded THC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
10y analysis · Full analysis span regression · 6 months rolling